Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.2.0.727
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Income Statement [Abstract]        
Sales $ 67,980 $ 177,459 $ 67,980 $ 177,459
Operating Expenses        
Selling, general and administrative 968,811 1,178,970 2,037,058 1,724,500
Research and development 872,234 899,662 1,719,368 1,469,017
Total operating expenses 1,841,045 2,078,632 3,756,426 3,193,517
Interest expense, net 108,227 64,759 252,205 156,977
Net loss during the development stage $ (1,881,292) $ (1,965,932) $ (3,940,651) $ (3,173,035)
Basic and diluted loss per share $ (0.01) $ (0.01) $ (0.02) $ (0.02)
Weighted average number of common shares outstanding 158,947,997 146,897,008 158,947,997 146,897,008